Skip to main content

The ARKG ETF Doesn’t Need More Catalysts. It’s Getting Them Anyway

The ARK Genomic Revolution Multi-Sector Fund (CBOE: ARKG) doesn’t need more catalysts, but in the rapidly evolving genomics spaces they keep on coming. ARKG is a substantial departure from the health care ETF most investors are accustomed to. That’s not a bad thing. “Securities within...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.